275 related articles for article (PubMed ID: 28297626)
1. Clinical Applications of the Genomic Landscape of Aggressive Non-Hodgkin Lymphoma.
Moffitt AB; Dave SS
J Clin Oncol; 2017 Mar; 35(9):955-962. PubMed ID: 28297626
[TBL] [Abstract][Full Text] [Related]
2. Molecular biology and genetics of lymphomas.
Hartmann EM; Ott G; Rosenwald A
Hematol Oncol Clin North Am; 2008 Oct; 22(5):807-23, vii. PubMed ID: 18954738
[TBL] [Abstract][Full Text] [Related]
3. Non-Hodgkin's lymphoma: the old and the new.
Cabanillas F
Clin Lymphoma Myeloma Leuk; 2011 Jun; 11 Suppl 1():S87-90. PubMed ID: 22035756
[TBL] [Abstract][Full Text] [Related]
4. Integrating understanding of epidemiology and genomics in B-cell non-Hodgkin lymphoma as a pathway to novel management strategies.
Glass S; Phan A; Williams JN; Flowers CR; Koff JL
Discov Med; 2016 Mar; 21(115):181-8. PubMed ID: 27115168
[TBL] [Abstract][Full Text] [Related]
5. [R.E.A.L. classification of non-Hodgkin lymphoma from the clinico-oncologic viewpoint].
Meusers P; Brittinger G
Praxis (Bern 1994); 1998 Jun; 87(23):793-800. PubMed ID: 9654985
[TBL] [Abstract][Full Text] [Related]
6. Driving toward precision medicine for B cell lymphomas: Targeting the molecular pathogenesis at the gene level.
Chung C
J Oncol Pharm Pract; 2020 Jun; 26(4):943-966. PubMed ID: 31964218
[TBL] [Abstract][Full Text] [Related]
7. T-cell and T/natural killer-cell lymphomas involving ocular and ocular adnexal tissues: a clinicopathologic, immunohistochemical, and molecular study of seven cases.
Coupland SE; Foss HD; Assaf C; Auw-Haedrich C; Anastassiou G; Anagnostopoulos I; Hummel M; Karesh JW; Lee WR; Stein H
Ophthalmology; 1999 Nov; 106(11):2109-20. PubMed ID: 10571346
[TBL] [Abstract][Full Text] [Related]
8. Class III beta-tubulin shows unique expression patterns in a variety of neoplastic and non-neoplastic lymphoproliferative disorders.
Yoon SO; Kim WY; Go H; Paik JH; Kim JE; Kim YA; Huh JR; Jeon YK; Kim CW
Am J Surg Pathol; 2010 May; 34(5):645-55. PubMed ID: 20220512
[TBL] [Abstract][Full Text] [Related]
9. Clusterin expression in malignant lymphomas: a survey of 266 cases.
Saffer H; Wahed A; Rassidakis GZ; Medeiros LJ
Mod Pathol; 2002 Nov; 15(11):1221-6. PubMed ID: 12429802
[TBL] [Abstract][Full Text] [Related]
10. Comparison of tumor mutation burden of 300 various non-Hodgkin lymphomas using panel based massively parallel sequencing.
Cho J; Yoon SE; Kim SJ; Ko YH; Kim WS
BMC Cancer; 2021 Aug; 21(1):972. PubMed ID: 34461835
[TBL] [Abstract][Full Text] [Related]
11. Catalog of genetic progression of human cancers: non-Hodgkin lymphoma.
Bödör C; Reiniger L
Cancer Metastasis Rev; 2016 Mar; 35(1):109-27. PubMed ID: 26957091
[TBL] [Abstract][Full Text] [Related]
12. Unique genomic features in adolescent and young adult, as compared to older adult, non-Hodgkin lymphoma and potential therapeutic targets.
Johnson A; Morosini D; Vergilio JA; Yelensky R; Rosenzweig M; Khaira D; Ali SM; Palma N; Lipson D; Juhn F; Erlich R; Stephens PJ; Ross JS; Miller VA; Wang K
Br J Haematol; 2017 Aug; 178(4):640-642. PubMed ID: 27291498
[No Abstract] [Full Text] [Related]
13. Transformative Clinical Trials in Non-Hodgkin and Hodgkin Lymphomas.
Abramson JS
Clin Lymphoma Myeloma Leuk; 2015 Jun; 15 Suppl():S141-6. PubMed ID: 26297267
[TBL] [Abstract][Full Text] [Related]
14. Genomic signatures in B-cell lymphoma: How can these improve precision in diagnosis and inform prognosis?
Iqbal J; Naushad H; Bi C; Yu J; Bouska A; Rohr J; Chao W; Fu K; Chan WC; Vose JM
Blood Rev; 2016 Mar; 30(2):73-88. PubMed ID: 26432520
[TBL] [Abstract][Full Text] [Related]
15. Peripheral T cell and natural killer (NK) T cell lymphomas: a clinicopathological study from a single Australian centre.
McKelvie PA; Thompson PA; Tam CS
Histopathology; 2012 Aug; 61(2):212-23. PubMed ID: 22716228
[TBL] [Abstract][Full Text] [Related]
16. Programmed death ligand 1 is expressed by non-hodgkin lymphomas and inhibits the activity of tumor-associated T cells.
Andorsky DJ; Yamada RE; Said J; Pinkus GS; Betting DJ; Timmerman JM
Clin Cancer Res; 2011 Jul; 17(13):4232-44. PubMed ID: 21540239
[TBL] [Abstract][Full Text] [Related]
17. Treatment approaches of hard-to-treat non-Hodgkin lymphomas.
Nandagopal L; Mehta A
Expert Rev Hematol; 2017 Mar; 10(3):259-273. PubMed ID: 28094575
[TBL] [Abstract][Full Text] [Related]
18. [Specifics of histopathological and genetical diagnosis and classification of lymphomas in children and adolescents].
Klapper W; Oschlies I
Klin Padiatr; 2012 Apr; 224(3):183-90. PubMed ID: 22513791
[TBL] [Abstract][Full Text] [Related]
19. Genomic stratification for the treatment of lymphomas.
Dave SS
Hematology Am Soc Hematol Educ Program; 2013; 2013():331-4. PubMed ID: 24319200
[TBL] [Abstract][Full Text] [Related]
20. Expression of CD95 antigen and Bcl-2 protein in non-Hodgkin's lymphomas and Hodgkin's disease.
Nguyen PL; Harris NL; Ritz J; Robertson MJ
Am J Pathol; 1996 Mar; 148(3):847-53. PubMed ID: 8774139
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
